Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
Home > Vol 39, No 1 (2021) > Chavananon

Gastrointestinal Tract Involvement of Langerhans Cell Histiocytosis: Concerning Point of Diagnosis

Shevachut Chavananon, Pornpun Sripornsawan, Thirachit Chotsampancharoen

Abstract

An 8-month-old girl presented with chronic mucous bloody diarrhea for 3 months. She was diagnosed as infective gastroenteritis and did not improve after antibiotic treatment. Three months subsequently, she was diagnosed with allergic gastroenteritis after developing generalized skin rash and was treated with amino acid-based formula but the symptoms of diarrhea deteriorated. The results of a biopsy of the gastrointestinal tract and skin lesions confirmed the diagnosis of Langerhans cell histiocytosis. Although Langerhans cell histiocytosis is uncommon with gastrointestinal tract involvement, Langerhans cell histiocytosis should be listed in the differential diagnosis for patients who present with chronic mucous bloody diarrhea that is unresponsive to multimodality treatment.

 Keywords

chronic mucous bloody diarrhea; gastrointestinal tract involvement; langerhans cell histiocytosis

 Full Text:

PDF

References

Hait E, Liang M, Degar B, Glickman J, Fox VL. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics 2006;118:1593-99.

Shima H, Takahashi T, Shimada H. Protein-losing enteropathy caused by gastrointestinal tract-involved Langerhans cell histiocytosis. Pediatrics 2010;125:426-32.

Yadav SP, Kharya G, Mohan N, Sehgal A, Bhat S, Jain S, et al. Langerhans cell histiocytosis with digestive tract involvement. Pediatr Blood Cancer 2010;55:748-53.

The French Langerhans’ Cell Histiocytosis Study Group. A multicenter retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.

Singhi AD, Montgomery EA. Gastrointestinal tract Langerhans cell histiocytosis: a clinicopathologic study of 12 patients. Am J Surg Pathol 2011;35:305-10.

Godoy MM, Fernandes M, Halenda GM, Javid G, Ngo PD. Gastrointestinal Langerhans cell histiocytosis. J Pediatr Gastroenterol Nutr 2014;59:17.

Abdullgaffar B, Al-Murbati B, Al-Falasi M, Al-Otaibi L. Unsuspected Langerhans cell histiocytosis can be easily missed in a colonic biopsy. Fetal Pediatr Pathol 2014;33:98- 103.

Barón GL, Olmedilla JM, Pérez AV, Melgar BA. Langerhans cell histiocytosis presenting as Enterocolitis and shock in neonate: J Pediatr Hematol Oncol 2019;41:155–7.

Vetter LS, Salinas JA, Martin SA, Guibelalde M, Ramon BP. Digestive tract symptoms in congenital Langerhans cell histiocytosis: a fatal condition in an illness usually considered benign. J Pediatr Hematol Oncol 2014;36:4.

Levy J, Khaskelberg A, Garvin J. Langerhans cell histiocytosis (LCH) involving the gastrointestinal tract: a clinical– electrogastrographic correlation. J Pediatr Gastroenterol Nutr 2001;33:511-4.

Geissmann F, Thomas C, Emile JF, Micheau M, Canioni D, Bensussan NC, et al. Digestive tract involvement in Langerhans cell histiocytosis. The French langerhans cell histiocytosis study group. J Pediatr 1996;129:836-45.

Braier J, Chantada G, Rosso D, Bernaldez P, Amaral D, Latella A, et al. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999;16:377-85.

Choi SW, Bangaru BS, Wu CD, Finlay JL. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. J Pediatr Hematol Oncol 2003;25:503-6.

DOI: http://dx.doi.org/10.31584/jhsmr.2020753

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2024

Journal Metrics


2020
Acceptance rate: 52%
2021
Acceptance rate: 27.8%
2022 (March)
Acceptance rate: 15.6%
2023 (June)
Acceptance rate: 23.6%


Submission to final decision
74 days

Acceptance to publication
40 days

SCImago Journal & Country Rank

About The Authors

Shevachut Chavananon
Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110,
Thailand

Pornpun Sripornsawan
Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110,
Thailand

Thirachit Chotsampancharoen
Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110,
Thailand

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Supported by

 

JHSMR now Indexed in



Scopus logo.svg






Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand Vietnam anxiety children computed tomography depression diabetes diabetes mellitus elderly knowledge mental health mortality prevalence quality of life risk factor risk factors stroke treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Open Journal Systems